Mark L. Smith

Chief Financial Officer, Vaxart.

Companies

Gevo, IncChief financial officer Feb 8, 2011 to Sep 18, 2013¹
Cardiovascular Systems IncChief financial officer Jun 27, 2006 to Mar 7, 2008²
VaxartChief financial officer Nov 3, 2003 to Feb 14, 2006³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vaxart VXRT32,851 shares⁴$15.1K at $0.46Feb 14, 2006

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 30, 2005Other 594 shares at $2.63 of Vaxart⁴
Nov 8, 2005I 17,393 shares at $3.52 of Vaxart⁵
May 31, 2005Other 1,228 shares at $10.58 of Vaxart⁶
Nov 30, 2004Other 1,057 shares at $12.30 of Vaxart⁷
May 31, 2004Other 1,337 shares at $9.23 of Vaxart⁸
Nov 30, 2003Other 1,949 shares at $5.94 of Vaxart⁹
May 31, 2003Other 1,707 shares at $5.94 of Vaxart¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGevo, Inc, Chief financial officer
2
SEC EDGARCardiovascular Systems Inc, Chief financial officer
3
SEC EDGARVaxart, Chief financial officer
4
SEC EDGARVaxart shares after the filing of Feb 14, 2006
5
SEC EDGARForm 4 filed Nov 10, 2005
6
SEC EDGARForm 4 filed Sep 15, 2005
7
SEC EDGARForm 4 filed Dec 20, 2004
8
SEC EDGARForm 4 filed Jun 22, 2004
9
SEC EDGARForm 4 filed Feb 6, 2004
10
SEC EDGARForm 4 filed Nov 3, 2003